Grants per year
Personal profile
Research Interests
Neurovascular Critical Care, Stroke, Stroke of unknown cause, stroke in young people, acute stroke therapy, atrial fibrillation, stem cell therapy for stroke.
Certifications and Licenses
| Vascular Neurology | |
| Neurology |
Training Experience
| 1997 | Internship, Mount Sinai Hospital, Illinois |
| 2000 | Residency, New York Presbyterian Hospital |
| 2001 | Fellowship, Univ. of CA-San Francisco Med. Ctr. |
Education/Academic qualification
Medicine, MD, PhD, Cornell University Medical College
… → 1996
Research interests keywords
- Stroke
Fingerprint
Dive into the research topics where Richard A Bernstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Grants
- 25 Finished
-
Stroke Trials Network - Regional Coordinating Stroke Centers
Prabhakaran, S., Bernstein, R. A. & Roth, E. J.
National Institute of Neurological Disorders and Stroke
8/1/16 → 7/31/18
Project: Research project
-
-
Protocol #1160-189: Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, oral b.i.d.) Versus Acetylsalicylic Acid (100 mg oral q.d.) in
Bernstein, R. A. & Caprio, F. Z.
Boehringer Ingelheim Pharmaceuticals, Inc.
8/21/15 → 8/21/19
Project: Research project
-
A Phase III, Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0 g Idarucizumab (BI 655075) in Patients Treated with Dabigatran Etexilate who have Uncontrolled Bleeding or Require Emer
Boehringer Ingelheim Pharmaceuticals, Inc.
4/6/15 → 4/6/18
Project: Research project
-
Study # D5134C00001: A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA [SOCRATES –Acute Stroke Or Transient IsChaemic Attack TReAted wi
AstraZeneca Pharmaceuticals LP
4/23/14 → 4/22/17
Project: Research project
-
Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke
Diener, H. C., Wachter, R., Wong, A., Thijs, V., Schnabel, R. B., Ntaios, G., Kasner, S., Rothwell, P. M., Passman, R., Saver, J. L., Albers, B. A. & Bernstein, R. A., Apr 2023, In: International Journal of Stroke. 18, 4, p. 400-407 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access1 Scopus citations -
Predictors of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: A Prespecified Secondary Analysis of the STROKE AF Randomized Clinical Trial
STROKE AF Investigators, Jan 1 2023, In: JAMA Neurology. 80, 1, p. 99-103 5 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
for the GLORIA-AF Investigators, May 1 2022, In: Clinical Research in Cardiology. 111, 5, p. 560-573 14 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Controversies in Stroke: Should Patients With Embolic Stroke of Undetermined Source Undergo Intensive Heart Rhythm Monitoring With an Implantable Loop Recorder?
Kim, A. S., Kamel, H., Bernstein, R. A., Manchanda, M. & Caprio, F. Z., Oct 1 2022, In: Stroke. 53, 10, p. 3243-3247 5 p.Research output: Contribution to journal › Review article › peer-review
2 Scopus citations -
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)
for the GLORIA-AF Investigators, May 1 2022, In: Clinical Research in Cardiology. 111, 5, p. 593 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access
Datasets
-
Monitoring for atrial fibrillation prior to patent foramen ovale closure after cryptogenic stroke
Diener, H. (Creator), Wachter, R. (Creator), Wong, A. (Creator), Thijs, V. (Creator), Schnabel, R. B. (Creator), Ntaios, G. (Creator), Kasner, S. (Creator), Rothwell, P. M. (Creator), Passman, R. S. (Creator), Saver, J. L. (Creator), Albers, B. A. (Creator), Bernstein, R. A. (Creator), Diener, H. (Creator), Thijs, V. (Creator) & Kasner, S. (Creator), SAGE Journals, 2022
DOI: 10.25384/sage.c.6204744.v1, https://sage.figshare.com/collections/Monitoring_for_atrial_fibrillation_prior_to_patent_foramen_ovale_closure_after_cryptogenic_stroke/6204744/1
Dataset
-
Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study
Pollack, C. V. (Creator), Bernstein, R. A. (Creator), Dubiel, R. (Creator), Reilly, P. (Creator), Gruenenfelder, F. (Creator), Huisman, M. V. (Creator), Kam, C. (Contributor), Kleine, E. (Creator), Levy, J. H. (Creator), Sellke, F. W. (Creator), Steiner, T. (Creator), Ustyugova, A. (Creator), Weitz, J. I. (Creator) & Chak-Wah, K. (Contributor), Taylor & Francis, 2017
DOI: 10.6084/m9.figshare.4476206.v2, https://tandf.figshare.com/articles/dataset/Healthcare_resource_utilization_in_patients_receiving_idarucizumab_for_reversal_of_dabigatran_anticoagulation_due_to_major_bleeding_urgent_surgery_or_procedural_interventions_interim_results_from_the_RE-VERSE_AD_sup_sup_study/4476206/2
Dataset